Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Perimeter Solutions, Inc.PRM · Entity 3914 | Director | February 26, 2026 | March 02, 2026 |
| SHERWIN WILLIAMS COSHW · Entity 2948 | SVP-Corp Plan, Develop & Admin | February 16, 2018 | February 21, 2018 |
| TransDigm Group INCTDG · Entity 2991 | Director | September 18, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Perimeter Solutions, Inc.
Report date February 26, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.80 · Expires 2035-02-12 | Direct | 6,194 |
Reported balance
After 2026-02-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-26 · Grant · Acquired 6,194 · Balance 6,194 F1: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.23 · Expires 2034-02-14 | Direct | 14,000 |
Reported balance
After 2026-02-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-26 · Grant · Acquired 7,000 · Balance 14,000 F2: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.50 · Expires 2033-09-06 | Direct | 21,000 |
Reported balance
After 2026-02-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-26 · Grant · Acquired 7,000 · Balance 21,000 F3: On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.88 · Expires 2033-02-15 | Direct | 21,000 |
Reported balance
After 2026-02-26 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-26 · Grant · Acquired 7,000 · Balance 21,000 F4: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.09 · Expires 2032-01-28 | Direct | 28,000 |
Reported balance
After 2026-02-26 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-26 · Grant · Acquired 7,000 · Balance 28,000 F5: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.80 · Expires 2031-12-07 | Direct | 7,000 |
Reported balance
After 2026-02-26 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-26 · Grant · Acquired 1,750 · Balance 7,000 F6: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock.
F2: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
F3: On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
F4: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
F5: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
F6: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock.
SHERWIN WILLIAMS CO
Report date February 16, 2018 · Filed February 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,788 |
Ending reported balance
After 2018-02-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-02-16 · Grant · Acquired 1,720 · Balance 70,594 F1: Represents the vesting of performance-based restricted stock units in an amount in excess of the target award previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2015 - 2017 performance period. The target amount was previously reported on a Form 4 filed February 19, 2015. Row 2 · 2018-02-16 · Tax withholding · Disposed 2,806 · Balance 67,788 |
| Common StockSEC Table I · non-derivative | IndirectStock Plan | 19,458.16 |
Reported balance
Holding disclosure · report date 2018-02-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 19,458.16 F2: Represents the number of shares of common stock attributable to the reporting person's participation in The Sherwin-Williams Company Employee Stock Purchase and Savings Plan per the trustee's 12/31/2017 statement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the vesting of performance-based restricted stock units in an amount in excess of the target award previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2015 - 2017 performance period. The target amount was previously reported on a Form 4 filed February 19, 2015.
F2: Represents the number of shares of common stock attributable to the reporting person's participation in The Sherwin-Williams Company Employee Stock Purchase and Savings Plan per the trustee's 12/31/2017 statement.
TransDigm Group INC
Report date September 18, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,836.09 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 46 · Balance 33,836.09 F1: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2020 Filed Mar 17, 2020 17:24 UTC | TransDigm Group INC TDG · Entity 2991 | GrantCommon Stock | 90 | $414.72 | $37,324.80 |
DisclosureSEC source: 0001209191-20-019503 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,904 F1 · shares: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. Read SEC document |
| March 17, 2020 Filed Mar 23, 2020 16:28 UTC Amendment | TransDigm Group INC TDG · Entity 2991 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020595 · doc4a.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,814 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:33 UTC | TransDigm Group INC TDG · Entity 2991 | GrantStock Option · Derivative | 3,000 | $0.00 Strike: $559.78 | $0.00 |
DisclosureSEC source: 0001209191-19-056997 · doc4.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-11-15 F1 · derivative.underlying_shares: Vest based on the achievement of annual per share operating performance targets between fiscal 2020 and fiscal 2024. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 15:40 UTC | TransDigm Group INC TDG · Entity 2991 | GrantCommon Stock | 68 | $439.87 | $29,911.16 |
DisclosureSEC source: 0001209191-19-020206 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,814 F1 · shares: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. Read SEC document |
| February 25, 2019 Filed Sep 27, 2024 22:52 UTC | TransDigm Group INC TDG · Entity 2991 | GiftCommon Stock | 288 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-110134 · ownership.xml · nonDerivative · entry 2 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,644.09 Read SEC document |
| September 14, 2018 Filed Sep 19, 2018 18:24 UTC | TransDigm Group INC TDG · Entity 2991 | GrantCommon Stock | 81 | $369.99 | $29,969.19 |
DisclosureSEC source: 0001209191-18-051607 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 F1 · shares: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. F1 · price: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. Read SEC document |
| June 07, 2018 Filed Sep 27, 2024 22:52 UTC | TransDigm Group INC TDG · Entity 2991 | GiftCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-110134 · ownership.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,932.09 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 00:29 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Tax withholdingCommon Stock | 2,806 | $401.08 | $1,125,430.48 |
DisclosureSEC source: 0001209191-18-011611 · doc4.xml · nonDerivative · entry 2 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,788 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 00:29 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011611 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,594 F1 · kind: Represents the vesting of performance-based restricted stock units in an amount in excess of the target award previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2015 - 2017 performance period. The target amount was previously reported on a Form 4 filed February 19, 2015. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 15:38 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 439 | $0.00 Strike: $227.73 | $0.00 |
DisclosureSEC source: 0001209191-17-061689 · doc4.xml · derivative · entry 3 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 439 shares Expires 2024-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 15:38 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Exercise / conversionCommon Stock | 439 | $227.73 | $99,973.47 |
DisclosureSEC source: 0001209191-17-061689 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Of shares listed, 4,500 are restricted stock units. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 16:22 UTC Amendment | TransDigm Group INC TDG · Entity 2991 | Exercise / conversionStock Option · Derivative | 4,700 | $0.00 Strike: $284.97 | $0.00 |
DisclosureSEC source: 0001209191-17-059909 · doc4a.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Underlying: Common Stock · 4,700 shares Expires 2027-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vest based on the achievement of annual per share operating performance targets between fiscal 2018 and fiscal 2022. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 15:12 UTC | TransDigm Group INC TDG · Entity 2991 | Exercise / conversionStock Option · Derivative | 4,700 | $0.00 Strike: $284.97 | $0.00 |
DisclosureSEC source: 0001209191-17-059887 · doc4.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Underlying: Common Stock · 4,700 shares Expires 2028-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vest based on the achievement of annual per share operating performance targets between fiscal 2018 and fiscal 2022. Read SEC document |
| October 18, 2017 Filed Oct 19, 2017 19:20 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $383.92 | $0.00 |
DisclosureSEC source: 0001209191-17-057445 · doc4.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2027-10-17 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2018. Read SEC document |
| August 08, 2017 Filed Aug 22, 2017 17:18 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GiftCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049798 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,435 F1 · balance_after: Of shares listed, 4,500 are restricted stock units. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 16:05 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 554 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001209191-17-028564 · doc4.xml · derivative · entry 4 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,446 Underlying: Common Stock · 554 shares Expires 2023-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 16:05 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GiftCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-028564 · doc4.xml · nonDerivative · entry 2 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,815 F1 · balance_after: Of shares listed, 4,500 are restricted stock units. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 16:05 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Exercise / conversionCommon Stock | 554 | $180.46 | $99,974.84 |
DisclosureSEC source: 0001209191-17-028564 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 13:16 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | Tax withholdingCommon Stock | 3,758 | $311.37 | $1,170,128.46 |
DisclosureSEC source: 0001209191-17-013016 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Corp Plan, Develop & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,636 F1 · balance_after: Of shares listed, 4,500 are restricted stock units. Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 14:50 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $270.12 | $0.00 |
DisclosureSEC source: 0001209191-16-146437 · doc4.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · SVP-Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2026-10-17 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 20:04 UTC | TransDigm Group INC TDG · Entity 2991 | GrantCommon Stock | 105 | $284.32 | $29,853.60 |
DisclosureSEC source: 0001209191-16-141978 · doc4.xml · nonDerivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,665 F1 · price: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the 2014 Stock Incentive Plan. F2 · balance_after: Total reflects common shares which were previously reported as restricted shares but as to which the restrictions have lapsed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.